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Rhabdomyolysis is a disorder characterized by acute damage of the sarcolemma of
the skeletal muscle leading to release of potentially toxic muscle cell components
into the circulation, most notably creatine phosphokinase (CK) and myoglobulin, and
is frequently accompanied by myoglobinuria. In the present work, we evaluated the
toxicity of p-phenylenediamine (PPD), a main component of hair dyes which is reported
to induce rhabdomyolysis. We studied the metabolic effect of this compound in
vivo with Wistar rats and in vitro with C2C12 muscle cells. To this aim we have
combined multi-omic experimental measurements with computational approaches
using model-driven methods. The integrative study presented here has unveiled the
metabolic disorders associated to PPD exposure that may underlay the aberrant
metabolism observed in rhabdomyolys disease. Animals treated with lower doses of
PPD (10 and 20 mg/kg) showed depressed activity and myoglobinuria after 10 h
of treatment. We measured the serum levels of aspartate aminotransferase (AST),
alanine aminotransferase (ALT), and creatine kinase (CK) in rats after 24, 48, and
72 h of PPD exposure. At all times, treatment with PPD at higher doses (40 and
60 mg/kg) showed an increase of AST and ALT, and also an increase of lactate
dehydrogenase (LDH) and CK after 24 h. Blood packed cell volume and hemoglobin
levels, as well as organs weight at 48 and 72 h, were also measured. No significant
differences were observed in these parameters under any condition. PPD induce
cell cycle arrest in S phase and apoptosis (40% or early apoptotic cells) on mus
musculus mouse C2C12 cells after 24 h of treatment. Incubation of mus musculus
mouse C2C12 cells with [1,2-13C2]-glucose during 24 h, subsequent quantification
of 13C isotopologues distribution in key metabolites of glucose metabolic network
and a computational fluxomic analysis using in-house developed software (Isodyn)
showed that PPD is inhibiting glycolysis, non-oxidative pentose phosphate pathway,
glycogen turnover, and ATPAse reaction leading to a reduction in ATP synthesis.
These findings unveil the glucose metabolism collapse, which is consistent with a
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decrease in cell viability observed in PPD-treated C2C12 cells and with the myoglubinuria
and other effects observed in Wistar Rats treated with PPD. These findings shed new
light on muscle dysfunction associated to PPD exposure, opening new avenues for
cost-effective therapies in Rhabdomyolysis disease.
Keywords: tracer-based metabolic data, metabolic modeling, metabolic pathways, p-phenylenediamine,
rhabdomyolysis
INTRODUCTION
Rhabdomyolysis is a degenerative muscle disease, whose
primary symptoms are muscle weakness, cramps, sweating, and
nausea, mainly because of muscle cells apoptosis (Melli et al.,
2005; Wilson, 2006). Although the multi-factorial nature of
rhabdomyolysis, a number of studies indicate that cell injury may
be mediated by a final common pathway (Melli et al., 2005).
Thus, a higher cellular permeability to sodium ions associated
to rhabdomyolysis can be triggered by diverse noxious factor,
such as toxins or drugs activating cytolytic enzymes, injuring
the cellular membrane, dysregulating metabolism and disrupting
the cell integrity, hypoxic conditions reducing energy production
in the cell, among others. Cytoplasmic sodium accumulation
increases cytosolic and mitochondrial calcium levels which
activates proteolytic enzymes affecting cell membrane integrity
and ultimately releasing cellular components to the circulation.
Thus, some of these components, such as myoglobin or creatine
kinase, facilitate clinical recognition of rhabdomyolysis (Melli
et al., 2005).
A variety of studies report the capability of p-
phenylenediamine (PPD) to induce skeletal muscle lesions
in rats. PPD is one of the main components of hair dyes, which
have been widely used to investigate the inflammatory and
degenerative pattern of muscle fibers (Garrigue et al., 2006;
Pourahmad et al., 2008; Zoll et al., 2015). PPD, together with
several of its amino alkyl derivates are known to be myotoxic in
animals and humans, causing necrosis of cardiac, and/or skeletal
muscle (Iannotti et al., 2010). To clarify the mechanism of
PPD related occurrence of rhabdomyolisys, we investigated the
pharmacological effects of PPD on the contractile proteins and
the sarcoplasmic reticulum (SR) in single skeletal mice muscle
fibers by using the skinned fiber method (Giulivi et al., 2011).
Thus, it was speculated that PPD can bring out rhabdomyolisys
by promoting the calcium-induced calcium release (CICR) and
leakage of Ca2+ from the SR, increasing Ca2+ concentration and
triggering subsequent changes in the muscle, such as irreversible
alterations in muscle structure, continuous contraction, and/or
metabolic changes (Giulivi et al., 2011).
PPD toxicity, and more specifically its role in rhabdomyolysis
initiation, has been demonstrated by experiments conducted by
administering PPD to mice (Chwaluk, 2013) that in turns alters
creatine kinase (CK) levels in blood (Wilson, 2006).
In the present work, we assessed the toxicity of PPD, the
antiproliferative effect on C2C12 cells by using Annexin V-
Fluorescein Isothiocyanate binding assay, the capacity to induce
cell cycle arrest, and apoptosis by applying FACS (fluorescence-
activated cell sorter) and the molecular mechanisms triggered by
this compound inducing rhabdiomyolysis in Wistar Rats and in
C2C12 cells by applying tracer-based metabolomic approaches.
Metabolism, as an effector of multiple cellular signals,
represents the end point of many cellular events. Thus,
metabolic characterization is a powerful tool to enhance our
understanding of how compounds such as PPD exert their
function on muscular cells in vitro. In this sense, the use
of tracer-based metabolic substrates (i.e., [1,2-13C2]-glucose)
combined with mass spectrometry (MS) permits to infer the
flux through the main metabolic reactions involved in the
biosynthetic metabolism and energy production of the cell.
This approach has been widely used in a number of studies
determine the metabolic flux profile of a variety of in vitro
models (Boren et al., 2003; Vizan et al., 2005; Burchert, 2007;
Kominsky et al., 2009). More specifically, metabolic isotope
distribution analysis (MIDA) or metabolic flux analysis via
model-driven approaches permit the simulation and evaluation
of substrate flux through major metabolic pathways under
various physiological conditions (Cowan-Jacob et al., 2004). In
order to correlate rhabdomyolysis and apoptosis associated to
PPD with characteristic metabolic patterns, we modeled glucose
metabolic network using available enzyme kinetic data, the
experimentally measured 13C isotopomer distribution data and
the previously developed software Isodyn (Selivanov et al., 2004,
2005, 2006). This approach enabled evaluating the metabolic
flux profiles in the analyzed metabolic network, which were
supported by the mass isotopomers distribution obtained after
incubation with labeled glucose in the presence of the PPD
compound.
MATERIALS AND METHODS
In vivo Assays with Wistar Rats; Test
Animals and Housing
The study was approved by the Ethics Committee on Animal
Experimentation of University of Navarra. Wistar female rats,
with a body weight of 160 g ± 20% (8 weeks old), were supplied
by Harlan (Harlan Laboratories, Indianapolis, IN). The animals
were housed in polycarbonate cages with stainless steel covers
in a room under controlled temperature conditions (22 ± 3◦C),
controlled relative humidity (50 ± 20%) and light (12 h light–
dark cycle). Air was exchanged 15 times/h sterile food supplied
by Harlan (Harlan Laboratories, Indianapolis, IN) and controlled
water was available ad libitum. The rats were housed in the
study room for 5 days prior to the beginning of treatment in
order to allow acclimatization to the environmental conditions.
Finally, three rats were randomly assigned to each studied group
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corresponding to different PPD doses (10, 20, 40, and 60 mg/Kg)
and control (DMSO).
Dosage and Observations
The animals were divided into groups of three rats at random.
A control group receiving the vehicle and four groups receiving
PPD at several concentrations 10, 20, 40, and 60 mg/kg at
single dose were included (Figure 1). The compound was
administered in a volume of 300 µl of 100% DMSO by gavage.
Animals were evaluated based on general appearance, behavior
and signs of morbidity using the Irwin test (Castagné et al.,
2012), immediately following administration, 30 min, 1, 2, 4,
and 8 h after the administration (Figure 1). All of the animals
were weighed just before the acclimatization period, before
administration and 24, 48, and 72 h after administration. At
the end of the observation period (24, 48, and 72 h after
administration), all the animals were anesthetized and blood
samples were collected from tail and retro orbital sinus and
centrifuged at 2000 × g for 30 min at 4◦C to recover
the serum (Figure 1). The serum was frozen and stored at
−20◦C until determination of biochemical parameters such
as urea, creatinin, Glucose, aspartate aminotransferase (AST),
alanine aminotransferase (ALT) and creatine kinase (CK), lactate
dehydrogenase (LDH), at 24, 48, and 72 h before sacrificed in
a CO2 chamber and autopsied. All of the tissues were observed
grossly. Ovaries, kidneys, liver, spleen, heart, and lung were
weighed and the relative organ weights were calculated. Serum
CK and LDH levels were measured.
Cell Culture
C2C12 cells from Mus musculus mouse were cultured in
DMEM (Dulbecco’s Modified Eagle’s medium) with 10 mg/ml
of streptomycin, 2 mM glutamine, 10,000 units/ml of penicillin
and 10% heat-inactivated FCS, until subconfluence was reached.
For biochemical characterization, C2C12 cells were cultured in
DMEM, supplemented with 4mMasparagine without glutamine,
10 mg/ml of streptomycin, 10,000 units/ml of penicillin and 10%
heat-inactivated FCS.
Cell Viability Assay
The absorbance of MTT [3-(4,5-Dimethylthiazol-2-Yl)-2,5-
Diphenyltetrazolium Bromide] dye staining of living cells was
used to determine cell viability (Pachon et al., 2007; Pachón
et al., 2008). Here, 3.5 × 103 C2C12 cells/well were cultured
in 96 well-plates at different PPD concentrations (from 1 to
100 µg/ml). An ELISA plate reader (Tecan Sunrise MR20-301,
TECAN, Austria) was used to determine the relative cell viability,
the absorbance was determined at 550 nm. Cell survival rate
relative to untreated cells after 24 h of treatment was used to
estimate the concentrations that caused 50% (IC50) and 80%
(IC80) of inhibition of C2C12 at that time.
Cell Cycle Analysis
Cell cycle was evaluated by measuring FACS (fluorescence-
activated cell sorter) in an Epics XL flow cytometer at 488 nm
(Coulter Corporation, Hialeah, FL, USA). This technique allows
for the semiquantitation of DNA in each cell and permits to
separate cells in G0 or G1 phase (one copy of DNA), G2 or
M phase (after DNA duplication) and S phase (the amount
of DNA per cell is in an intermediate state between the two
previous conditions). For these measurements, C2C12 cells were
cultivated in 6 well-plates (4 × 105 cells/well each) with 2 ml of
culture medium. After 24 h of plated, PPD corresponding to IC50
and IC80 concentrations was added and cells were incubated for
24 h, in parallel, control C2C12 cells were cultured without PPD.
All experiments were performed five times with two replicates for
each experiment.
Annexin V-Fluorescein Isothiocyanate
Binding Assay
This technique permits to determine whether a cell is at
early or late apoptosis or necrotic state. In early apoptosis,
Phosphatidylserine (PS) is translocated to the outer membrane
allowing PS-annexin V-Fluorescein Isothiocyanate (FITC)
binding. In late apoptosis, as well as in necrotic processes, cell
membranes lose their integrity allowing PI to access the nucleus
and bind the DNA bases. Next, by using FACS analysis one can
determine PI and annexin V-FITC staining accumulation to
differentiate non-apoptotic cells (PI– and annexin V–) from early
apoptotic (PI− and annexin V+) and necrotic or late apoptotic
(PI+) cells (Cortés et al., 2012). The same amount of C2C12
cells mentioned for cell cycle assay was treated with PPD as
previously described. Cells were then collected and resuspended
in binding buffer (10 mM Hepes/NaOH, pH7.4, 140 mM NaCl,
2.5 mMCaCl2). Annexin V-FITC conjugate (1µg/ml) was added
and incubated for 30min at room temperature in the dark.
Just before FACS analysis [Bender medSystems (Innogenetics)
human Annexin V-FITC Kit cat No. BMS306FI], cells were
stained with 1 mg/ml PI solution. In each experiment ∼20 ×
103 cells per condition were analyzed and the experiment was
performed five times.
Statistics
Data is represented as the mean value from independent
experiments ± SEM. The statistical analysis, comparing the
threated and the control untreated cells, was carried out by using
the Student’s t-test. This is a widely used statistical analysis to
compare two populations’ means with unknown variance and
assuming normal distribution.
Biochemical Characterization of C2C12
Cells
Glucose and lactate concentrations were determined from culture
medium at initial and end-time points by using Cobas Mira
Plus chemistry analyzer (HORIBA ABX, Montpellier, France;
Cisternas et al., 2016).
Metabolic Profile of C2C12
To track and measure the substrate carbon flux through
central carbon metabolic pathways of C2C12 cells when treated
with PPD, mass isotopomer distribution analysis (MIDA), and
metabolic modeling approaches were used.
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FIGURE 1 | Experimental design for the dose-effect in vivo studies of PPD on Wistar Rats. Rats were divided in one basal group, one control group (only
DMSO administered) and four groups with an increasing PPD concentration with three individuals per group. Rats’ behavior is observed at different time points until
8 h after treatment. Next, blood sample is extracted from one mice of each group and it is sacrificed for tissue and organ examination. This process is repeated at 24,
48, and 72 h after treatment.
Sample Preparation
Cells were cultured in DMEM (Biowithaker) ◦supplemented with
10% dialyzed heat-inactivated Fetal Bovine Serum (FBS), glucose
(10mM, 50% isotope enrichment [1,2-13C2]-glucose), asparagine
(20 mg/ml), penicillin (100 U/ml), and streptomycin (100
µg/ml). PPD was added to the flasks at the IC50 concentration
determined for 24 h (154 µM), in parallel, control C2C12 cells
were cultured without PPD. Initially each flask contained 106
cells and the incubation was carried out for 24 h. To separate
medium and cell pellets, cells were centrifuged at the end of
incubation (3000 × g, 5min). Afterwards, pellet and medium
were stored at−20◦C for metabolite isolations.
Metabolite Isolation and Derivatization
The following metabolites were isolated and derivatized for their
quantification in PPD-treated and non-treated C2C12 cells:
Glucose. A mixed DOWEX 50-DOWEX 1 ionic exchange
column was used to corroborate that the original medium
contained 50% of labeled glucose ([1,2-13C2] D-glucose). First,
500 µl of medium and after 6 ml of milliQ water were passed
through the column and were collected into a glass tube. Next,
it was lyophilized for 12 h to eliminate the remaining liquid
and the dried sample was stored. Finally, hydroxyl-amine in
pyridine and acetic anhydride were used to derivatize glucose
to its aldonitrile form. The ion cluster was set to m/z 328
(C1–C6, chemical ionization; Wamelink et al., 2008).
Glycogen. Glycogen for biochemical and isotopomerics
distribution determination was extracted as described in
Burchert (2007), by direct digestion of sonicated extracts
with amyloglucosidase. Measurement of glucose released
from glycogen was done by using the isotopomer [U-
13C6-1,2,3,4,5,6,6-D7]D-glucose (or [U-13C-D7]-glucose as
shorter name) as recovery standard and internal standard
quantification procedures. The hydrolyzed glucose was
isolated using ion exchange chromatography (Mao et al.,
2002) and was derivatized to its aldonitrile acetate form
using hydroxyl-amine in pyridine and acetic anhydride. We
monitored the ion cluster around the m/z 328 (C1–C6,
chemical ionization; Wamelink et al., 2008).
Lactate. Lactate from the culture media of C2C12 cells,
which had been cultured and treated as explained above, was
extracted by ethyl acetate. In more detail, 1 ml of culture
medium was acidified with 2–3 drops of HCl, followed by
addition of 1 ml of ethyl acetate and a little amount of sodium
chloride and 1 min shaken. Next, the samples rest for 2 min
and were centrifugated at 4,000 rpm for 10 min in a Jouan
B3.11 centrifuge. Next, organic phase was transferred to a
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tube and the remaining ethyl acetate was removed by applying
aa slight N2 pressure for 10–15. Lactate was derivatized to
its propylamideheptafluorobutyric form. Next, the m/z 328
was monitored (C1–C3, chemical ionization, Wamelink et al.,
2008).
Ribose from RNA. Acid hydrolysis of the cellular RNA was
used to isolate ribose from C2C12 treated and non-treated
cells with the fractions as indicated above. First, 1 ml of Trizol
was added and dissolved by sonication (30 s) to the cold
pellets, next, it was transferred to free RNase eppendorfs and
200 µl of chloroform were added. Next, the samples were
shaken and centrifuged in an Eppendorf microfuge for 30
min at 14,000 rpm at 4◦C. Chloroform and RNA from the
non-colored upper phase was collected and 1 ml of cold 2-
propanol was added and the mixture was reposing overnight
to precipitate the DNA. Next, samples were centrifuged as
indicated above. RNA was further purified by removing the
supernatant, next 1 ml of 75% cold ethanol was added.
The samples were shaken and centrifuged to eliminate the
supernatant and re-suspended with 10 µl of miliQ water and
2 ml of HCl 2N. Next, the samples were heated at 100◦C for 2
h, cooled at room temperature (acid hydrolysis of RNA) and
dried with air preasured to eliminate the remaining liquid or
stored stored at−80◦C. Acetic anhydride and hydroxyl-amine
in pyridine were used to derivatize ribose to the aldonitrile
acetate form. Finally, the 13C molar enrichment in ribose
was quantified by setting the ion cluster at m/z 256 (C1–C5,
chemical ionization, Wamelink et al., 2008).
Glutamate. Glutamate was extracted from the culture media
of cultured and treated C2C12 cells by using ammoniac and
acetic acid. In more detail, 1 ml of culture medium was passed
through the previously prepared ionic exchange column
DOWEX 50. Next, 6 ml of milliQ water and after 5 ml of
NH4OH 2N were passed through the column, the volume was
collected into a glass tube and immediately dried eliminating
the remaining liquid by air pressure. Then, 6 ml of milliQ
water were added to the tube and passed through to DOWEX
1 ionic exchange column earlier prepared, Next, 5 ml of acetic
acid CH3COOH 0.5N were also added and the total volume
was collected. Finally, samples were dried with air pressure for
12 h and stored for determination. Glutamate was derivatized
to its nitrifluoroacetyl-n-butyl form The ion clusters m/z
198 and 152 (C2–C5 and C2–C4 electron impact ionization,
respectively) were monitored. Isotopomeric analysis of
glutamate C2–C5 and C2–C4 fragments from cultured
medium to infer the relative contributions of pyruvate
dehydrogenase and pyruvate carboxylase to the tricarboxylic
acid (TCA) cycle (Cowan-Jacob et al., 2004; Yoo et al., 2008).
Gas Chomatography/Mass Spectrometry (GC/MS). Mass
spectral data were obtained on the HP5973 mass selective
detector connected to an HP6890 gas chromatography. The
settings were as follows: GC inlet 230◦C, transfer line 280◦C,
MS source 230◦C,MSQuad 150◦C. AnHP-5 capillary column
(30m length, 250 µm diameter, 0.25 µm film thickness)
was used for glucose, lactate, ribose, and glutamate analysis
(Wamelink et al., 2008). A Bpx70 column (25-m length, 220-
µm diameter, 0.25-film thickness; SGE Incorporated, Austin,
TX) was used for fatty acids analysis with specific temperature
programming for each compound studied.
Computational Modeling of Tracer-Based
Metabolic Data
Transfer of 13C carbons from medium [1,2-13C2]-glucose
into intracellular metabolites was simulated by using in-house
developed software for stable isotope tracer data analysis
(Selivanov et al., 2004, 2005, 2006; Isodyn, Marin de Mas
et al., 2011). The simulation scheme included all isotope-
exchange reactions in pentose phosphate pathway, TCA cycle,
glycolysis, anaplerotic reactions, exchange with extracellular
lactate, glutamate and glucose, ATPmetabolism, and biosynthetic
fluxes (Figure 2). In brief, the software iteratively finds a set
of parameters that defines a metabolic flux profile to simulate
the metabolic label distribution that best fits the experimental
measurements. Finally, to evaluate the reliability of the analysis,
χ2 statistic is used to compare computed and measured label
distributions as is described in Equation (1). Here, yi is
the experimental fraction measurement of the ith isotope of
metabolite y, y(xi,a) is the computed fraction of the same isotope
and σi is the standard deviation of the ith isotope of metabolite y.
χ2 =
N∑
i= 1
[
yi − y(xi, a)
σi
]2
(1)
This software enables to integrate tracer-based metabolic data
and metabolite consumption/production rates to infer the
internal metabolic fluxes in control and PPD-treated cells.
A more detailed description of Isodyn software is in the
Supplementary Material 2.
Data Analysis and Statistical Methods
Three cultures for each treatment were used for the in vitro
experiments. In mass spectral analyses, three independent
automatic injections were performed for each sample. Sample
measurements with a standard deviation higher than 1% of the
normalized peak intensity were rejected. Level of significance
was determining by performing Mann-Whitney U-test, with
two independent samples (three replicates of each one of the
two samples, having six measurements in total). This is a non-
parametric test applied to compare two independent sample
populations. Differences in glucose carbon metabolism between
control and PPD with an associated p ≤ 0.05 were considered as
significant.
RESULTS
PPD Presents Toxic Effects and Alters the
Molecular Biomarkers in Blood on Wistar
Rats
Increasing doses of PPD (from 10 mg/Kg of body weight to
60 mg/kg of body weight) was administered to Wistar female
rats. Immediately after administration, all of the animals showed
a decreased spontaneous reactivity, which lasted between 10 h
and 2 days, depending on the doses (Table 1). These symptoms
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FIGURE 2 | The schemes of kinetic model used as a base for simulation of isotopologue distribution. Arrows represent biochemical reactions connecting
metabolites. Pathways considered in the model are enclosed and highlighted in different colors: red, glycolysis; blue, pentose phosphate pathways; orange, TCA
cycle, and green glycogen metabolism. The metabolites enclosed in ellipses are considered to be in fast equilibrium. List of abbreviations for metabolites: glu,
glutamate; glc, glucose; glgn, glycogen; lac, lactate; g6p, glucose 6 phosphate; fbp, fructose 1,6-bisphosphate; f6p, fructose 6-phosphate; g3p, glyceraldehyde
3-phosphate; dhap, dihydroxyacetone phosphate; pyr, pyruvate; accoa, acetyl coenzyme A; pep, phosphoenolpyruvate; e4p, erythrose 4-phosphate; r5p, ribose
5-phosphate; s7p, sedoheptulose 7-phosphate; xu5p, xylulose 5-phosphate; cit, citrate; oaa, oxaloacetic acid; mal, malate; adp, adenosine diphosphate, and atp,
adenosine triphosphate. Enzymes: hk, hexokinase; g6pase, glucose 6-phosphatase; g6pdh: glucose 6-phosphate dehydrogenase; gp, glycogen phosphorylase; gs,
glycogen synthase; pfk, phosphofructokinase; fbp, fructose 1,6-bisphosphatase; ald, aldolase; pk, pyruvate kinase; pepck, phosphoenolpyruvate carboxykinase;
pdh, pyruvate dehydrogenase complex; pc, pyruvate carboxylase; cs, citrate synthase; atpase, ATP synthesis; pepg3, pathway pep→g3p; g3pep, pathway
g3p→pep; mal-oaa, pathway mal→oaa; oaa-mal, pathway oaa→mal; transaldolase activity, ta1, f6p→s7p; ta2: s7p→ f6p; ta3, f6p↔g3p; and ta4, s7p↔e4p;
transketolase activity: tk1, x5p→s7p; tk2, s7p→x5p; tk3, f6p→x5p; tk4, x5p→f6p; tk5, f6p→s7p; tk6, s7p→f6p; tk7, x5p↔g3p; tk8, f6p↔e4p; and tk9, r5p↔s7p.
were not observed in the control animals. The evolution of
body weight was normal in all groups. Changes in the general
state, external appearance or behavior were observed along the
observation period in animals treated with PPD and a general
depressed activity and piloerection which lasted from 10 h until
death, depending on the doses (Table 1). Animals treated with
PPD at lower doses (10 and 20mg/kg) until 10 h of treatment,
showed depressed activity and some of they had brown color
urine or myoglobinuria. Animals treated with higher doses of
PPD (40 and 60 mg/kg) until 4 h of treatment, showed total
loss of equilibrium, hypotonic gait and piloerection. After 48 h
of treatment with PPD at 60 mg/kg, mices they ataxic gait, but
this effect disappeared after 72 h of treatment. After 48 and 72
h of treatment, one animal of each group of PPD treatment was
sacrificed and necropsied.
Biochemical parameters in blood were measured at 24, 48, and
72 h after PPD dosage. Results obtained with animals treated
with PPD compound indicate that AST and ALT (Figure 3A)
increased at 24, 48, and 72 h, and LDH and CK enzymes
(Figure 3A) increased at 24 h after the final dose of treatment at
higher doses of PPD (40 and 60 mg/kg).
Blood packed cell volume and hemoglobin levels, as well
as organs weight at 48 and 72 h, were also measured. No
significant differences were observed in these parameters under
any condition. Histological analysis of the different extracted
organs showed patterns similar to controls.
TABLE 1 | Toxicity after oral administration of four concentrations of PPD
compound in mg/kg.
Compound Doses Hipoactivity Piloerection Ataxic. G Hypot. G Myoglo
PPD 10 10 h 2–4 h 0/3 0/3 ++
20 10 h 2–4 h 0/3 0/3 ++
40 1 day Until death 2/3 0/3
60 2 days Until death 0/3 3/3
DMSO 300 µl 30 min 1 h 0/3 0/3
The compound was dissolved in DMSO and 300 µl of solution was administered. Animals
were sacrificed after 48 and 72 h of observational period. Periods of time are in hours (h),
days or minutes (min). ++ represents the presence of myoglobinuria; Ataxic G, Ataxic
Gait; Hypot G, Hypotonic Gait; Myoglo, Myoglobiunuria.
Antiproliferative Effect of PPD on C2C12
Cells
The antiproliferative effect of PPD was assessed in C2C12
cells after 24 h of incubation. The IC50 concentrations were
obtained by MTT test. PPD concentrations were plotted against
the percentage of cell proliferation after 24, 48, and 72 h of
incubation. The IC50-values obtained in C2C12 cells were 154 ±
6, 108 ± 8, and 59 ± 1 µM at 24, 48, and 72 h, respectively and
the IC80-values were 201± 8, 182± 12, and 91± 7 µM at 24, 48,
and 72 h, respectively (Figure 3B).
Frontiers in Molecular Biosciences | www.frontiersin.org 6 March 2017 | Volume 4 | Article 8
Marín de Mas et al. PPD Metabolic Toxicity in Muscle
FIGURE 3 | (A) LDH, CK, AST, and ALT levels after 24, 48, and 72 h of PPD treatment at different doses administration in Wistar rats, control group (CT) and the
enzyme levels before PPD administration (B). The measurements are given in U/L (International unit of enzymatic activity per liter). (B) Effect of PPD doses (in µg) on
cell proliferation of C2C12 cells, after 24, 48, and 72 h of incubation. The relative percentage of cell proliferation was calculated assuming a 100% of proliferation in
untreated cells at 24, 48, and 72 h. Each point represents the mean of triplicate experiments. (C) Cell cycle analysis of C2C12 treated with PPD. C2C12 cells were
exposed to PPD for 24 h at 37◦C with either IC50 or IC80 (second and third column, respectively) concentrations, or the solvent (first column as control) were stained
with propidium iodide to conduct the cell cycle analysis of five independent experiments. Values are represented as the mean ± SE. *Significantly different at p < 0.05
compared with control cells. (D) C2C12 cells were stained with propidium iodide accumulation and Annexin V-FITC and exposed to PPD in the flow cytometry
analysis. The concentrations used in this study corresponded to IC50 and IC80 (second and third column, respectively), or the solvent (first column as control) for 24 h.
Results are mean ± SD of five independents experiments.
Cell Cycle and Apoptosis
C2C12 cells treated with PPD at IC50 and IC80
concentrations after 24 h of treatment showed an increase
in the population in S phase (13% at IC50, and 28%
at IC80 for C2C12 cells, respectively) compared to
untreated cells. It was accompanied by a concomitant
decrease in the percentage of cells in the G0/G1 phases
(19% at IC50, and 32% at IC80 for C2C12 cells),
suggesting an arrest at the S-phase in PPD-treated cells
(Figure 3C).
Apoptosis in C2C12 cells was assessed after 24 h of treatment
with PPD using the concentrations mentioned in cell cycle
analysis. We differentiate late apoptotic/necrotic cells (annexin
PI− and V+) from early apoptotic cells (annexin V+ and PI−)
by performing FACS analysis using annexin V-FITC staining
and PI accumulation. Results showed that C2C12 cells treated
with PPD at IC50 concentration increase apoptosis in 55%
(34.7 and 18.8% of early and late apoptosis, respectively) with
respect to the untreated cells. We also observed that cells treated
with PPD at IC80 concentration increased apoptosis in 43%
(20.1% early apoptosis plus 23.9% late apoptosis) compared
with non-treated C2C12 cells (Figure 3D). Annexin-V binding
assay showed that PPD induced a high number of apoptotic
cells.
Determining Differences in Central Carbon
Metabolism Activity in C2C12 Cells Treated
with PPD via Mass Isotopomer Distribution
Analysis (MIDA)
Glucose
Glucose consumption and lactate production were determined
by using spectrophotometric methods following 24 h of
incubation of C2C12 cells treated with PPD at IC50.
The results didn’t show differences between the initial
and the final 13C enrichment in glucose (46.3% of
[1,2-13C2]-glucose, glucose m1 in Figure 4A -m0, non-
labeled; m1, containing one 13C isotope; m2, two 13C
isotopes, etc...), which indicates that no glucose was
released.
Lactate
An approximate estimation of the metabolic flux through
the pentose phosphate pathway (ppp) and glycolysis can be
inferred by measuring the 13C label distribution in lactate
(Lactate isotopologue distribution is depicted in Figure 4A).
The two 13C labeled lactate (m2 in Figure 4A) is directly
produced via glycolysis, whereas one 13C labeled lactate
(m1 in Figure 4A) is the product of the oxidation of
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FIGURE 4 | (A) Isotopologues are described as follows: non-labeled (m0), m1, containing one 13C isotope (m1), m2 (two 13C isotopes (m2), etc. Predicted and
measured isotopologues from isolated C2C12 cells using glucose as the only substrate and containing 50% of [1,2-13C2]D-glucose. The results correspond to
lactate, glutamate, and glucose from medium, glucose from glycogen after 24 h exposed to PPD and non-exposed (control) cells. The measurements are presented
as mean ± standard deviation and the predicted label distribution for each isotopologue is represented with red points. The data was simulated using a model in
accordance with the scheme presented in Figure 2. The fitting was carried out by applying an algorithm described in Marin de Mas et al. (2011). The difference
between experimental data and the best fit (Section Materials and Methods) are summarized for the whole set of data. The whole isotope distribution can be found in
the Supplementary Material 1. (B) Principal fluxes of central carbon metabolism estimated in control and PPD-treated C2C12 cells. This table shows the fluxes with
significant differences between groups (p < 0.05). Fluxes are expressed as mmol × mL−1 min−1 × flux hk. Abbreviations used in this table correspond to flux
notation in Figure 2. The whole isotope distribution can be found in the Supplementary Material 1. (C) Graphical representation of the kinetic model used for
isotopologue distribution simulation. Principal fluxes of central carbon metabolism estimated in control and PPD-treated C2C12 cells. Metabolic reactions highlighted
in red represent predicted fluxes significantly higher in control cells (no reactions with higher flux in PPD-treated group were predicted). Abbreviations used in this figure
correspond to flux notation in Figure 1.
[1,2-13C2]-glucose via oxidative branch of pentose-phosphate
pathway and then recycled to glycolysis through the non-
oxidative branch of pentose-phosphate pathway (Wamelink
et al., 2008). Thus, the percentage of glucose metabolized
directly to lactate can be determined by applying the formula:
Glycolitic rate = [1lactate × m2lactate]/[1glucose × m2glucose],
where 1glucose is the glucose consumption (Control: 2.31
± 0.04mM; PPD: 2.42 ± 0.26 mM) and 1lactate is the
lactate production (Control: 2.5 ± 1.0 mM; PPD: 1.5 ±
0.3 mM). Here, we didn’t find significant differences in the
glycolitic rate between the PPD-treated and control cells
(28.8 ± 14 and 31.9 ± 13%, respectively). Additionally,
we did not observe significant enrichment in m1 lactate
isotopomer which indicates a low activity of ppp and that
glucose was metabolized to lactate mainly through glycolysis
in both groups. The results also showed that glycolytic
contribution to lactate production is higher in non-treated
C2C12 cells.
Glycogen
We didn’t observe significant differences in the total glycogen
reservoirs in the C2C12 cells after 24 h of incubation in none
of the groups (10.1 µg of glycogen). Furthermore, significant
13C incorporation was observed in glycogen after incubation.
More specifically glycogen was enriched in m2 species in both
groups (glycogen m2 in Figure 4A), which suggests an important
exchange between medium [1,2-13C2]-glucose, and glycogen
reservoirs. On the other hand,m1 isotopologue was no significant
in both groups (glycogen m1 in Figure 4A) which suggest a low
contribution of ppp to glycogenmetabolism in C2C12 cells and is
supported by our previous analysis of glucose and lactate labeling
data.
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Ribose
To estimate the nucleic acid precursor synthesis in C2C12
cells treated with PPD, measurements of the molar enrichment
of RNA ribose from [1,2-13C2]-glucose were carried out by
calculating the overall 13C enrichment by applying the following
formula: 6mn = m1 + 2 × m2 + 3 × m3 + 4 × m4 + 5 ×
m5. This calculation showed that 6mn ribose label enrichment
significantly decrease after treatment with PPD (0.294± 0.028 in
control and 0.197 ± 0.023 in PPD-treated cells), which indicates
an inhibition of de novo nucleic acid synthesis in treated cells
compared with control cells.
Additionally, we found significant differences in the balance
between non-oxidative and oxidative branch of pentose-
phosphate pathway between control and PPD-treated cells. It was
determined by calculating the ratio between both branches of ppp
as is described in Wamelink et al. (2008): ox/non-ox = m1 +
m3 / (m2+m3+ 2m4). Here, we found that this ratio was 1.183
± 0.004 in control cells and 2.224 ± 0.189 in PPD-treated cells.
These differences are mainly due to the low activity of the non-
oxidative branch of pentose-phosphate pathway in PPD-treated
cells as the glucose consumption is driven to lactate production
and no r5p is recycled to glycolysis. Besides, the activity of the
oxidative branch of pentose-phosphate pathway is also lower in
PPD treated cell decreasing the molar enrichment in ribose.
Moreover, these results correlate with the fact that m1 lactate
isotopomer was almost undetected (Supplementary Material 1)
in both groups, suggesting that in both conditions glycolysis is
the preferred pathway to glucose consumption.
Glutamate
Glutamate, a non-essential amino-acid, is partially produced
from mitochondrial α-ketoglutarate, which is a central
intermediate of the TCA cycle. Therefore, label incorporation
from glucose into glutamate is a good indicator of TCA cycle
anabolic metabolism for amino acid synthesis instead of glucose
oxidation (Wamelink et al., 2008). The analysis did not reveal
significant 13C enrichment in glutamate in any of both C2C12
cells groups.
Unveiling Metabolic Flux Alterations in
C2C12 Cells Treated with PPD via
Model-Driven Method
In order to perform a more in-depth analysis of the tracer-based
metabolic data and to identify the key metabolic adaptations
associated to the PPD in C2C12 cells, we performed a
computational fluxomic analysis. To this aim we used in-
house developed software (Selivanov et al., 2006; Isodyn,
Marin de Mas et al., 2011 and Supplementary Material 3).
This software presents an excellent platform to integrate
tracer-based metabolic data into a detailed computational
model of the central carbon metabolism and enables to infer
the metabolic flux profile that best explains the observed
metabolic label distribution in both control and PPD-treated
cells. Label distributions were integrated along with their
concentrations in Isodyn. The results obtained with this software
corroborated the previous results while enabled to have an
overall view of the metabolic fluxes distribution (Figures 4A,B).
As is described in Materials and Methods Section, we used
the statistic χ2 to evaluate the reliability of our model
predictions. Thus, the relatively low χ2-values obtained in
this analysis in both control and PPD-treated cells (5.78
and 8.27, respectively, see Supplementary Material 1) indicate
that the computed isotopologue fractions were consistent with
the experimental measurements. The predicted isotopologue
fractions (Figure 4A) are the result of a metabolic flux profile
that in turn is defined by a set of kinetic parameters that
minimize the difference between the calculated and measured
isotopologue distribution (Supplementary Material 1). Thus,
differences between groups in the calculated metabolic flux
profile may define the metabolic processes underlying the
aberrant metabolism associated to the exposure to PPD in
C2C12 muscle cells. The calculated metabolic flux profile is
depicted Figures 4A,B (see also Supplementary Material 1).
Our model-driven analysis predicted a higher flux (relative
to glucose uptake) through most of the glycolytic reaction in
control group compared with PPD-treated cells, which indicates
a higher glycolitic activity and is consistent with the higher
label incorporation observe in lactate in control cells. Our
computational analysis also predicted a higher glycogen turnover
in control group which could explain the observed higher label
incorporation. In addition, it was predicted a higher rate of
xilulose-5-phosphate metabolization from fructose-6-phosphate
in control group (through f6 → X5 reaction in Figures 4A,B)
which is supported by a higher activity of the non-oxidative
branch of ppp and the higher label incorporation to pentoses
phosphate observed in control group that is discussed in previous
sections. The lower pentose phosphate production predicted in
PDD-treated cell may partially explain the decrease in the cell
viability observed in C2C12 cell when are exposed to PPD.
Finally, the model also predicted a high ATPase activity (atpase
reaction in Figures 4A,B) in control group which is consistent
with the higher cell viability that requires a more active energy
metabolism.
DISCUSSION
PPD poisoning effects are characterized by vomiting and
acute respiratory distress caused by a severe oedema
of face, neck, pharynx, larynx, and upper airways. In a
minority of the cases, hematuria, sometimes hemolysis and
methaemoglobinuria, and acute renal failure also appear
as late effects (Soni et al., 2009; Hooff et al., 2011). In the
present study, animals treated with PPD at higher doses (40
and 60 mg/kg) presented the effects corresponding to both
phases.
Although multiple factors can trigger rhabdomyolysis, it may
be mediated by a final common pathway leading to muscle cell
injury (muscle necrosis) and ultimately releasing cell components
into the circulation (Melli et al., 2005). Our results show elevated
levels of serum CK, LDH and aminotransferase enzymes (which
are very specific markers for skeletal muscle injury) inWistar rats
treated with PPD. These findings are is in accordance with the
primary diagnostic indicator of rhabdomyolysis.
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Other cause of the rhabdomyolysis is the accumulation of
sodium in the cytoplasm that leads to increase intracellular
calcium concentration (Chavez et al., 2016). Here, calcium
accumulation is mediated by several factors: (i) cell injury
by itself, (ii) an enhanced Na+/Ca2+ exchange to compensate
the excess sodium, and (iii) ATP depletion that reduce Ca2+-
dependent ATPase activity and promotes Ca2+ accumulation
(Hortelano Araque et al., 2008). Skinned fiber method has
been applied to study the pharmacological effects of PPD on
sarcoplasmic reticulum (SR) and contractile proteins in rat
skeletal muscle fibers (Fajardo et al., 2013). Thus, it has been
speculated that PPD can trigger rhabdomyolisys by promoting
Ca2+ leakage from SR and calcium-induced calcium release
(CICR), which lead to higher Ca2+ intracellular levels and
promotescontinuous contraction and structural and metabolic
changes in the muscle (Giulivi et al., 2011).
This fact can be related with the effect observed in animals
treated with the higher doses of PPD, which showed hypoactivity,
hypotonic, and ataxic gait during the treatment with this
compound. In this sense our model-driven analysis predicted
a significant reduction in the ATPase activity in C2C12 cells
exposed to PPD. The lower flux through ATPase reaction is
consistent with the biological observation previously discussed.
In addition, it implies a reduced ATP production in PPD-treated
cells which is also associated to rhabdomyolysis disease and may
partially explain the higher cell viability observed in control cells
that requires a more active energy metabolism.
The other important finding frequently observed in
rhabdomyolysis is myoglobinuria. Myoglobinuria is always
accompanied by rhabdomyolysis, but not necessarily the other
way around. Urinary myoglobin provokes a typical reddish-
brown (port-wine-like) color, even in absence of hematuria.
Myoglobin is rapidly and unpredictably eliminated by hepatic
metabolism (Wilson, 2006). After 24 h of treatment with PPD
compound all animals had urine brown color but in absence
of hematuria; nevertheless, 48 and 72 h after treatment this
effect disappears. These facts could indicate that the effect of
PPD is higher in early treatments because serum enzymes
value gradually normalized and some symptoms disappeared,
although the muscular weakness persisted for 3 days.
Furthermore, we studied how PPD-induced rhabdomyolysis
affects central carbon metabolism in C2C12 muscle cell
line. Thus, a first prospective approach applying metabolic
Isotopomer Distribution Analysis (MIDA) showed significant
differences in metabolic pathway patterns when C2C12 cells were
treated with PPD to induce rhabdomyolysis. More specifically,
we found that glucose was metabolized to lactate mainly through
glycolysis in both treated and non-treated C2C12 cells. However,
glycolytic contribution to lactate production is higher in non-
treated C2C12 cells. The low label incorporation observed in
Glutamate suggest a reduced activity of TCA cycle in C2C12 cells,
disruption of glyclolysis by PPD may provoke ATP depletion,
leading to Ca+ accumulation related with rhabdomyolysis due
to consequent low activity of ATP-depending Ca channel. On
the other hand, LDH liberation after PPD treatment may explain
glycolytic inhibition, since LDH is needed to support glycolysis
by recycling produced NADH to NAD+.
Additionally, differential changes in pentose phostphate
pathways have been also observed. PPD cause a decrease in de
novo synthesis of ribose-5-phosphate for nucleotide synthesis.
The balance between non-oxidative and oxidative branches of
pentose-phosphate pathway also decreased in PPD treated cells.
Since oxidative branch of pentose-phosphate pathway is used not
only for pentose phosphate synthesis but also for the generation
of reduction power as NADPH, this decrease may affect cellular
detoxification machinery of Reactive Oxygen Species (ROS;
Dodson et al., 2013). Since ROS are well-known to trigger
apoptosis (Halliwell, 2006), effects on ppp may correlate with
effects on cell proliferation in vitro caused by these compounds,
and specially, PPD inhibition of oxidative branch of ppp may
explain enhanced apoptosis observed in treated cells (40% of
apoptotic cells).
To further explore the metabolic effects of PPD-induced
rhabdomyolysis we perform a metabolic flux analysis based
kinetic modeling approach to analyze the tracer-based metabolic
data of PPD-treated and control C2C12 cells. Our model-driven
analysis permitted us to infer the metabolic flux alterations
associated to PPD exposure. More specifically, our analysis
suggests a higher glycolysis utilization compared with ppp
activity in C2C12 cells which is in accordance with a higher
enrichment of m2 lactate isotopologue (lactate generated from
[1,2-13C2]-glucose via glycolysis) compared with m1 lactate
isotopologue (lactate generated from [1,2-13C2]-glucose via
glycolysis) in both cell groups. Furthermore, our model-driven
analysis predicted a higher glycolytic activity relative to glucose
consumption in control group that is consistent with the
higher label incorporation observe in lactate in these cells. Our
analysis also predicted a higher flux through the transketolase
reaction that transforms fructorse-6-phosphate to xilulose5-
phosphate in non-treated cells that is consistent with higher
label enrichment in ribose-5-phosphate in control cells and
with the MIDA analysis concluding a higher activity in the
non-oxidative branch of ppp in control cells. Finally, the
analysis determined a decrease in the flux through ATPase
reaction leading to a reduction in ATP synthesis in treated cells.
Gathering these evidences we have an overview in which PPD
reduces ribose and ATP production which is consistent with
the reduction in cell viability observed in PPD-treated C2C12
cells an in Wistar Rats and is supported by the experimental
evidences.
In conclusion, the present study demonstrates that PPD
induces some pathologic signs involved in rhabdomyolysis
such as muscle necrosis, release of muscle components into
the circulation, myoglobinuria, and muscle injury. Moreover,
the present study has proven the potential of stable isotope
techniques to understand the effects of PPD on central carbon
metabolism. Ourmodel-driven analysis has permitted to quantify
the intracellular metabolic fluxes and the changes associated to
PPD exposure which enabled a more in-depth understanding of
the metabolic processes underlying the adverse effects associated
with rhabdomyolysis on the C2C12 muscle cells. Thus, our
work sheds new light on muscle dysfunction associated to
PPD, opening new avenues for cost-effective therapies in
Rhabdomyolysis disease.
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